ANGELICO, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 12.313
AS - Asia 3.408
EU - Europa 2.130
SA - Sud America 515
AF - Africa 74
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
Totale 18.456
Nazione #
US - Stati Uniti d'America 12.169
SG - Singapore 1.603
CN - Cina 523
IT - Italia 502
BR - Brasile 405
RU - Federazione Russa 381
HK - Hong Kong 369
VN - Vietnam 287
GB - Regno Unito 209
DE - Germania 208
IE - Irlanda 178
FI - Finlandia 177
IN - India 126
BD - Bangladesh 115
JP - Giappone 115
FR - Francia 100
UA - Ucraina 98
CA - Canada 91
NL - Olanda 71
SE - Svezia 49
AR - Argentina 46
ID - Indonesia 46
KR - Corea 41
TR - Turchia 38
MX - Messico 37
AT - Austria 30
ES - Italia 27
PL - Polonia 23
IQ - Iraq 17
BE - Belgio 16
ZA - Sudafrica 16
CZ - Repubblica Ceca 14
EC - Ecuador 14
EG - Egitto 14
PH - Filippine 14
SA - Arabia Saudita 14
CL - Cile 13
NG - Nigeria 12
TH - Thailandia 11
MY - Malesia 10
CO - Colombia 9
GR - Grecia 9
PY - Paraguay 9
TN - Tunisia 9
UZ - Uzbekistan 9
CH - Svizzera 8
VE - Venezuela 8
AZ - Azerbaigian 7
EU - Europa 7
KE - Kenya 7
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
IL - Israele 6
LT - Lituania 6
MA - Marocco 6
NP - Nepal 6
PE - Perù 6
DZ - Algeria 5
JM - Giamaica 5
JO - Giordania 5
MD - Moldavia 5
HR - Croazia 4
HU - Ungheria 4
TM - Turkmenistan 4
AM - Armenia 3
GE - Georgia 3
HN - Honduras 3
IR - Iran 3
KG - Kirghizistan 3
KZ - Kazakistan 3
RO - Romania 3
TW - Taiwan 3
UY - Uruguay 3
BO - Bolivia 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
LK - Sri Lanka 2
OM - Oman 2
PT - Portogallo 2
A1 - Anonimo 1
BH - Bahrain 1
BJ - Benin 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GI - Gibilterra 1
IM - Isola di Man 1
IS - Islanda 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
LY - Libia 1
MG - Madagascar 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
Totale 18.451
Città #
Wilmington 2.592
Houston 2.270
Woodbridge 2.007
Singapore 800
Ashburn 448
Fairfield 431
San Jose 402
Hong Kong 360
New York 342
Council Bluffs 309
Ann Arbor 247
Chandler 247
Beijing 230
Seattle 172
Dublin 171
Cambridge 168
Santa Clara 133
Medford 131
Helsinki 129
Los Angeles 126
The Dalles 103
Tokyo 97
Rome 88
Ho Chi Minh City 87
Elk Grove Village 86
Jacksonville 82
Buffalo 78
Moscow 76
Hanoi 68
Lawrence 60
Lauterbourg 53
São Paulo 49
Chicago 48
Orem 42
Milan 41
Jakarta 40
San Diego 38
Dearborn 37
Chennai 33
Munich 31
Dallas 30
Montreal 30
Zhengzhou 30
Frankfurt am Main 27
London 25
Toronto 25
North Bergen 24
Nuremberg 24
Creede 23
Redondo Beach 23
Atlanta 22
Lappeenranta 22
Amsterdam 21
Boardman 20
Dong Ket 20
Warsaw 18
Brooklyn 17
Manchester 17
Menlo Park 16
Phoenix 16
Poplar 16
Vienna 16
Denver 15
Mülheim 15
Salt Lake City 15
Seoul 15
Miami 14
Stockholm 14
Brasília 12
Da Nang 12
Istanbul 12
Johannesburg 12
Paris 12
Turin 12
Ankara 11
Mexico City 11
Rio de Janeiro 11
Engelhard 10
Nanjing 10
Brussels 9
Columbus 9
Dhaka 9
Haiphong 9
Jeddah 9
Jersey City 9
Mountain View 9
Quito 9
San Francisco 9
Santiago 9
Belo Horizonte 8
Boston 8
Madrid 8
Mumbai 8
Tashkent 8
Aydin 7
Curitiba 7
Falls Church 7
Guangzhou 7
Monte Vista 7
Nairobi 7
Totale 13.819
Nome #
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 670
Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. 492
Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients 488
Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: Two case reports 482
Conversion to rapamycin immunosuppression for malignancy after kidney transplantation 461
Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis. 459
Management of spermatic cord liposarcoma in renal transplant recipients: case report 447
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C 436
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. 428
Prospective study of switch from cyclosporine to tacrolimus for fibroadenomas of the breast in kidney transplantation. 427
Prospective randomised comparison of Rubber Band Ligation(RBL) and Combined Hemorrhoidal Radiocoagulation(CHR) 421
The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up 421
Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis 421
Surgical antibiotic prophylaxis after renal transplantation: time to reconsider. 414
One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: A randomized, controlled clinical trial 414
Ambulatory therapy with combined hemorrhoidal radiocoagulation 410
Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation. 377
Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients 372
Liver transplantation for hepatitis B and C virus-related cirrhosis: mid-term results 365
Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand? 339
Longterm Survival and Cost-Effectiveness of Immunosuppression Withdrawal After Liver Transplantation 333
Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger? 330
Donation after circulatory death in paediatric liver transplantation: current status and future perspectives in the machine perfusion era 324
Impact of remnant vital tissue after locoregional treatment and liver transplant in hepatocellular cancer patients, a multicentre cohort study 306
Outcomes of left split graft transplantation in Europe: report from the European Liver Transplant Registry 266
Liver Transplantation For HDV/HBV Coinfection In Italy: An Intention-To-Treat Analysis Of Long-Term Outcomes 246
A national mandatory-split liver policy: A report from the Italian experience 231
Everolimus and enteric-coated mycophenolate sodium Ab initio after liver transplantation: Midterm results 224
Aggressive prevention and preemptive management of vascular complications after pediatric liver transplantation: A major impact on graft survival and long-term outcome 223
The COVID-19 outbreak in Italy: initial implications for organ transplantation programs 220
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature 205
How do synchronous lung metastases influence the surgical management of children with hepatoblastoma? An update and systematic review of the literature 190
Screening of Fabry Disease of patients in renal replacement therapy in a population from Lazio (Italy) 187
Using a weaning immunosuppression protocol in liver transplantation recipients with hepatocellular carcinoma: A compromise between the risk of recurrence and the risk of rejection? 172
Ante situm liver resection with inferior vena cava replacement under hypothermic cardiopolmunary bypass for hepatoblastoma: Report of a case and review of the literature 157
Laparoscopic adrenalectomy for hemorrahagic adrenal pseudocyst discovered during pregnancy: Report of a case 156
A matched pair analysis of multicenter longterm follow-up after split-liver transplantation with extended right grafts 154
Colorectal cancer in ulcerative colitis after liver transplantation for primary sclerosing cholangitis: a systematic review and pooled analysis of oncological outcomes 150
Kidney Transplantation in the Hepatitis C Infected Recipient 147
Moving forward in the treatment of cholangiocarcinoma 130
Fairness and pitfalls of the Italian waiting list for elective liver transplantation: The ECALITA registry study 126
The hamletic dilemma of patients waiting for kidney transplantation during the COVID-19 pandemic: to accept or not to accept (an organ offer)? 123
Current strategies to minimize ischemia-reperfusion injury in liver transplantation: a systematic review 113
Improving outcomes of in situ split liver transplantation in Italy over the last 25 years 112
Pancreatic Adeno-MiNEN, a Rare Newly Defined Entity with Challenging Diagnosis and Treatment: A Case Report with Systematic Literature Review and Pooled Analysis 105
The Enhanced Recovery after Surgery (ERAS) Pathway Is a Safe Journey for Kidney Transplant Recipients during the “Extended Criteria Donor” Era 104
Chronic rejection after liver transplantation: Opening the Pandora's box 104
Repeat laparoscopic hepatectomy for recurrent tumors is safe and feasible. An Invited Commentary on "Perioperative outcomes comparing laparoscopic with open repeat liver resection for post-hepatectomy recurrent liver cancer: a systematic review and meta-analysis" (Int J Surg 2020; Epub ahead of print) 103
Combined endovascular-surgical treatment for complex congenital intrahepatic arterioportal fistula: A case report and review of the literature 101
“Salus Populi Suprema Lex”: Considerations on the Initial Response of the United Kingdom to the SARS-CoV-2 Pandemic 101
Effects of Anti-COVID-19 Vaccination and Pre-Exposure Prophylaxis with Tixagevimab-Cilgavimab in Kidney and Liver Transplant Recipients 98
Electronic Outpatient Referral System for Liver Transplant Improves Appropriateness and Allows First Visit Triage 98
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service 96
Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy 96
Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor 95
Same donor laparoscopic liver and kidney procurement for sequential living donor liver-kidney transplantation in primary hyperoxaluria type i 94
The Enhanced Recovery After Surgery Pathway Is Safe, Feasible and Cost-Effective in Delayed Graft Function After Kidney Transplant 94
Mechanism, potential, and concerns of immunotherapy for hepatocellular carcinoma and liver transplantation 92
Is routine hepaticojejunostomy at the time of unplanned surgical bypass required in the era of self-expanding metal stents? 91
Safety and efficacy of simultaneous liver transplantation and sleeve gastrectomy in morbid obese patients with end-stage liver disease: the LT-SG study 90
Hepatocellular carcinoma in children: Hepatic resection and liver transplantation 89
Evaluation of Humoral Response following SARS-CoV-2 mRNA-Based Vaccination in Liver Transplant Recipients Receiving Tailored Immunosuppressive Therapy 89
First human liver transplantation using a marginal allograft resuscitated by normothermic machine perfusion 88
A novel mobile phone application for infant stool color recognition: An easy and effective tool to identify acholic stools in newborns 88
The impact of center volume on the utilization and outcomes of machine perfusion technology in liver transplantation: An international survey 86
Successful clinical and virological outcomes of liver transplantation for HDV/HBV-related disease after long-term discontinuation of hepatitis B immunoglobulins 86
Intraductal Papillary Neoplasms of the Bile Duct: Clinical Case Insights and Literature Review 85
What Is the Role of Minimally Invasive Liver Surgery in Treating Patients with Hepatocellular Carcinoma on Cirrhosis? 85
Cell transplantation-based regenerative medicine in liver diseases 85
Graft weight integration in the early allograft dysfunction formula improves the prediction of early graft loss after liver transplantation 85
Awareness and Impact of Non-pharmaceutical Interventions During Coronavirus Disease 2019 Pandemic in Renal Transplant Recipients 84
How future surgery will benefit from SARS-COV-2-related measures: a SPIGC survey conveying the perspective of Italian surgeons 83
Temporal trends of waitlistings for liver transplantation in Italy: the ECALITA (Evolution of IndiCAtion in LIver transplantation in ITAly) registry study 83
Towards tolerance in liver transplantation 83
Current status of liver surgery for non-colorectal non-neuroendocrine liver metastases: the NON.LI.MET. Italian Society for Endoscopic Surgery and New Technologies (SICE) and Association of Italian Surgeons in Europe (ACIE) collaborative international survey 83
Global management of a common, underrated surgical task during the COVID-19 pandemic: Gallstone disease - An international survery 82
Adult liver transplantation in the congenital absence of inferior vena cava 82
An international multicentre study of protocols for liver transplantation during a pandemic: A case for quadripartite equipoise 82
Urological Complications in Kidney Transplant Recipients: Analysis of the Risk Factors and Impact on Transplant Outcomes in the Era of “Extended Criteria Donors” 80
Primary Prophylaxis for Gastrointestinal Bleeding in Children With Biliary Atresia and Portal Hypertension Candidates for Liver Transplantation: A Single-Center Experience 79
The efficacy and safety of mammalian target of rapamycin inhibitors ab initio after liver transplantation without corticosteroids or induction therapy 78
Higher retransplantation rate following extended right split-liver transplantation: An analysis from the eurotransplant liver follow-up registry 78
Laparoscopic liver resection for hepatocellular carcinoma in Fontan-associated chronic liver disease. The first case report 76
Feasibility and cost effectiveness of ambulatory laparoscopic cholecystectomy. A retrospective cohort study 76
Rescue liver transplantation after post-hepatectomy acute liver failure: A systematic review and pooled analysis 73
Maple Syrup Urine Disease and Domino Liver Transplantation: When and How? 73
The management of immunosuppression in kidney transplant recipients with COVID-19 disease: an update and systematic review of the literature 72
COVID-19 in a pregnant kidney transplant recipient - what we need to know: A case report 71
Vascular involvements in cholangiocarcinoma: tips and tricks 71
Current management of hepatobiliary malignancies between centers with or without a liver transplant program: A multi-society national survey 68
Severe Unresolved Cholestasis Due to Unknown Etiology Leading to Early Allograft Failure Within the First 3 Months of Liver Transplantation 68
Surgical management of colon cancer in ulcerative colitis patients with orthotopic liver transplant for primary sclerosing cholangitis. A systematic review 67
Life-saving vascular access after combined liver and kidney transplantation: A challenging access to the right atrium 66
Heterogeneous indications and the need for viability assessment: An international survey on the use of machine perfusion in liver transplantation 64
Health economics aspects of kidney transplantation in Sicily: a benchmark analysis on activity and estimated savings 63
The Effects of Sustained Immunosuppression Withdrawal After Liver Transplantation on Metabolic Syndrome 63
Normothermic Machine Perfusion of Deceased Donor Liver Grafts Is Associated with Improved Postreperfusion Hemodynamics 61
COVID-19, liver transplant, and immunosuppression: allies or foes? 59
Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients 58
Immunosuppression protocols for emerging oncological indications in liver transplantation: A systematic review and pooled analysis 57
Totale 18.180
Categoria #
all - tutte 62.732
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.732


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022651 42 63 19 17 20 54 54 26 77 74 29 176
2022/2023794 82 61 7 72 72 167 70 126 50 11 50 26
2023/2024408 47 20 42 9 49 87 29 8 13 34 8 62
2024/20252.666 52 412 238 226 64 305 182 74 231 328 278 276
2025/20265.778 390 252 489 483 502 413 703 726 602 553 387 278
2026/202722 22 0 0 0 0 0 0 0 0 0 0 0
Totale 18.910